Skip to main content
Premium Trial:

Request an Annual Quote

BD Gets FDA OK, CLIA Waiver for Flu Test

NEW YORK (GenomeWeb News) – Becton Dickinson today said that it has received both US Food and Drug Administration clearance and a CLIA waiver for its new BD Veritor System for rapid detection of Flu A+B.

According to the company, BD Veritor is the first rapid influenza test system that incorporates a digital read out of results to receive CLIA waiver.

The system reports performance measured against polymerase chain reaction results. It incorporates BD's Nano Detection Particle and Adaptive Read Technology, requires little sample preparation time, and can run the test in 10 minutes.

"The new BD Veritor System provides a new approach for CLIA-waived rapid tests for influenza A+B by offering a combination of speed, accuracy, and convenience with an objective read that physicians can trust," Tom Polen , president of BD Diagnostics – Diagnostic Systems, said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.